Novel treatment strengthens bones in genetic disease neurofibromatosis type-1
An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.
Aug 14, 2014
0
0